United States HR 3327: Drug Price Transparency for Medicare Patients Act of 2019

Status: Referred to the Subcommittee on Health. (as of 2019-06-19)

State: United States · Session: 116 · Bill: HR 3327

Subjects: Consumer affairs, Government information and archives, Inflation and prices, Marketing and advertising, Prescription drugs

Sponsors: Francis Rooney, Daniel William Lipinski

View United States HR 3327 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.